Your browser doesn't support javascript.
loading
Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients.
Ahlén Bergman, Emma; Hartana, Ciputra Adijaya; Johansson, Markus; Linton, Ludvig B; Berglund, Sofia; Hyllienmark, Martin; Lundgren, Christian; Holmström, Benny; Palmqvist, Karin; Hansson, Johan; Alamdari, Farhood; Huge, Ylva; Aljabery, Firas; Riklund, Katrine; Winerdal, Malin E; Krantz, David; Zirakzadeh, A Ali; Marits, Per; Sjöholm, Louise K; Sherif, Amir; Winqvist, Ola.
Afiliação
  • Ahlén Bergman E; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. emma.ahlen.bergman@ki.se.
  • Hartana CA; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Johansson M; Department of Urology, Sundsvall Hospital, Sundsvall, Sweden.
  • Linton LB; Department of surgical and perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
  • Berglund S; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Hyllienmark M; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Lundgren C; TLA Targeted Immunotherapies AB, Stockholm, Sweden.
  • Holmström B; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Palmqvist K; Department of Urology, Akademiska University Hospital, Uppsala, Sweden.
  • Hansson J; Department of surgical and perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
  • Alamdari F; Department of Surgery, Urology Section, Östersund County Hospital, Östersund, Sweden.
  • Huge Y; Centre for Research and Development, Faculty of Medicine, Uppsala University, County Council of Gävleborg, Uppsala, Sweden.
  • Aljabery F; Department of Urology, Västmanland Hospital, Västerås, Sweden.
  • Riklund K; Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden.
  • Winerdal ME; Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden.
  • Krantz D; Department of Radiation Sciences, Diagnostic Radiology, Umeå University, Umeå, Sweden.
  • Zirakzadeh AA; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Marits P; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Sjöholm LK; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Sherif A; Department of surgical and perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
  • Winqvist O; Unit of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Clin Epigenetics ; 10(1): 102, 2018 08 03.
Article em En | MEDLINE | ID: mdl-30075815

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Linfócitos T CD4-Positivos / Análise de Sequência de DNA / Metilação de DNA Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Linfócitos T CD4-Positivos / Análise de Sequência de DNA / Metilação de DNA Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article